Martinez-Vega, R., Mbacham, W. F., Ali, I., Nji, A., Mousa, A., Beshir, K. B., . . . Chico, R. M. (2024). Parasite clearance and protection from Plasmodium falciparum infection (PCPI): A three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3–5 years of age in Cameroon. BMC Infectious Diseases, 24(1), 1-12. https://doi.org/10.1186/s12879-024-09868-y

Martinez-Vega, Rosario, et al. "Parasite Clearance and Protection from Plasmodium Falciparum Infection (PCPI): A Three-arm, Parallel, Double-blinded, Placebo-controlled, Randomised Trial of Presumptive Sulfadoxine-pyrimethamine Versus Sulfadoxine-pyrimethamine Plus Amodiaquine Versus Artesunate Monotherapy Among Asymptomatic Children 3–5 Years of Age in Cameroon." BMC Infectious Diseases 24, no. 1 (2024): 1-12. https://doi.org/10.1186/s12879-024-09868-y.

Martinez-Vega, Rosario, et al. "Parasite Clearance and Protection from Plasmodium Falciparum Infection (PCPI): A Three-arm, Parallel, Double-blinded, Placebo-controlled, Randomised Trial of Presumptive Sulfadoxine-pyrimethamine Versus Sulfadoxine-pyrimethamine Plus Amodiaquine Versus Artesunate Monotherapy Among Asymptomatic Children 3–5 Years of Age in Cameroon." BMC Infectious Diseases, vol. 24, no. 1, 2024, pp. 1-12, https://doi.org/10.1186/s12879-024-09868-y.